
Every dollar of untapped 340B savings, every missed manufacturer discretionary discount, and every orphan drug exclusion decision eventually lands on one desk. That desk belongs to the Chief Pharmacy Officer (CPO).
In any healthcare organization, coordinators manage the details and directors oversee daily operations. But the CPO is responsible for the overall success of the program.
This is not just a theory. A CPO’s decision depends on the ceiling price calculations, orphan drug exclusion rules, and changing drug prices. A coordinator may notice that an orphan drug discount is no longer available. In contrast, the CPO decides how that impacts the budget, staffing, and formulary planning for the months ahead.
As orphan drug pricing has grown more complex and more discretionary, this role has moved from a back-office title to a seat at the executive table, right alongside the CFO and CMO. This page covers what a Chief Pharmacy Officer actually does, how the role fits above the 340B coordinator function, what it takes to qualify, and where outside CPO consulting fits when a hospital needs executive-level pharmacy strategy without a full-time hire.
A Chief Pharmacy Officer is the senior executive responsible for a healthcare system's pharmacy strategy, operations, and compliance. This person reports to hospital leadership. They/she/he sits alongside other C-suite positions and not under a single department head.
Here are the key responsibilities of a CPO:
To set up strategic direction for pharmacy services across every facility in the health system.
To own accountability for 340B ceiling price compliance and orphan drug savings capture.
To decide how much of the 340B and discretionary pricing workload sits in-house versus with an outside compliance partner.
To ensure regulatory compliance across state and federal pharmacy law.
To represent pharmacy in executive budget decisions alongside the Chief Financial Officer (CFO) and Chief Medical Officer (CMO).
Pharmacy leadership follows a hierarchy. The Chief Pharmacy Officer sits at the top of it in most healthcare systems. They /she/he is directly positioned above the 340B coordinator function covered elsewhere on this site.
Here are the key differences between the role and responsibilities of a 340B coordinator, Director of Pharmacy, and CPO:
| Pharmacy Leadership Role | Scope of Each | 340B and Orphan Drug Involvement |
|---|---|---|
| 340B coordinator | Daily program administration at the facility level |
Manages:
|
| Director of pharmacy | Runs pharmacy operations for one facility |
|
| Chief Pharmacy Officer | Executive oversight of pharmacy strategy across an entire health system |
|
There is no single fixed path to this role, but most Chief Pharmacy Officers share a similar foundation, and increasingly that foundation includes direct 340B program experience.
Most candidates spend years moving through staff pharmacist, coordinator, and director roles before reaching this level. A CPO who has personally reconciled split-billing errors or tracked a manufacturer's discretionary pricing shift tends to make quick and informed calls on orphan-drug strategy.
Here are the qualifications to become a CPO:
| Qualification | Typical Requirement |
|---|---|
| Education | Doctor of Pharmacy (PharmD) from an accredited program |
| Licensure | Active state pharmacist license in the state of practice |
| Board certification | Often Board-Certified Pharmacotherapy Specialist (BCPS) or another board certification. This is not always mandatory. |
| Experience | Typically 8 to 10-plus years in hospital pharmacy, including 340B or specialty program leadership |
| Advanced management training | Master of Business Administration (MBA) or Master of Healthcare Administration (MHA). You can either hold an equivalent healthcare administration degree or coursework. |
Not every hospital has the volume or budget to justify a full-time Chief Pharmacy Officer. However, every hospital still needs someone making executive-level calls on 340B strategy, orphan drug discretionary pricing, and compliance oversight. Without that layer, the coordinator function operates without direction, and untapped 340B savings tend to sit unclaimed longer than they should.
340B Orphan Drug Solutions works alongside hospital pharmacy leadership to assist with:
Strategic 340B and orphan drug program oversight. We do this without a full-time executive salary.
Quarterly discretionary pricing and ceiling price reviews. We report these directly to leadership.
Direct support for your coordinator or Director of Pharmacy on compliance and budget planning
Reporting built for pharmacy staff, hospital boards, and executive teams
A CPO has the following responsibilities:
● To lead pharmacy strategy
● To manage operations
● To overlook budgeting and compliance across a healthcare system
● To hold ultimate accountability for 340B program performance and orphan drug savings capture
Within a hospital or health system, the CPO is generally the highest pharmacy leadership post. This individual sits above 340B coordinators and pharmacy directors.
On the other hand, at the federal level, the CPO of the U.S. Public Health Service holds a comparable top position for pharmacists in government service.
Here is how you can become a CPO:
● By holding a Doctor of Pharmacy degree
● By having an active pharmacist license. This is often a board certification such as BCPS.
● By having eight or more years of hospital pharmacy leadership experience. You should have direct 340B or specialty drug program exposure.
● By getting an MBA or MHA.
Most hospitals cannot justify a full-time executive salary purely for pharmacy strategy, especially the small ones. However, every hospital still needs someone making informed calls on 340B compliance and orphan drug discretionary pricing. Outsourcing gives a hospital that executive layer. Also, it gives you the specialized attention discretionary pricing needs, without the cost or hiring risk of a permanent role.
A CPO improves financial performance by closing the gap between what a hospital is entitled to under 340B and what it actually captures. This individual closes the gap by:
● Catching untapped savings
● Keeping discretionary pricing. This is done by tracking prices closely enough to act on manufacturer changes.
● Building a pharmacy budget. The finance team can actually rely on the report quarter to quarter.
A CPO sets the compliance policy that a coordinator executes day-to-day. They/she/he decides how the hospital tracks diversion prevention and duplicate discount prevention. The CPO is also responsible for orphan drug documentation. They also decide when internal staff can carry that workload and when it needs outside support. This is the call that determines whether a program stays consistently audit-ready or ends up reactive.
Talk to 340B Orphan Drug Solutions about CPO consulting support built around your hospital's pharmacy leadership structure. This can mean backing up your coordinator or covering the executive layer entirely.
Disclaimer
This content is provided for general informational purposes only and does not constitute legal, regulatory, reimbursement, or financial advice. All savings figures, examples, and calculations on this page are illustrative estimates, not guarantees. Actual 340B and orphan drug savings vary based on manufacturer pricing decisions, patient population, drug mix, and 340B compliance status. Covered entities should confirm current requirements directly with HRSA's Office of Pharmacy Affairs and consult qualified counsel before making compliance or purchasing decisions.

Maximizing savings. Ensuring compliance. Advancing access to life-changing therapies.
© 2026 340B Orphan Drug Solutions. All rights reserved.